Simplification From Protease Inhibitors to Raltegravir

NCT00941083 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

240

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Raltegravir (Use RAL as a simplification strategy)
DRUG: Raltegravir (Use RAL as a simplification strategy)
DRUG: Raltegravir (Use RAL as a simplification strategy)

Sponsor

Hospital Carlos III, Madrid